Furthermore, miR-149-3p was found to be increased in U87-MG glioma cells after quinidine, a voltage-gated K+ channel blocker therapy, which caused glioma cell proliferation to be inhibited and apoptosis to be induced (47). Here, KCND3 is linked to central nervous system cancer.